US president, Donald Trump, has issued a hammer blow to the pharmaceutical sector by announcing a 100% tariff on drug imports.
The tariff will apply to all companies, unless they’ve begun to construct a US based manufacturing plant.
What this means for the two Swiss drug giants, Novartis and Roche, is unclear at the moment – but both companies have already announced they plan to invest billions in the United States over the next five years.
Trump has previously demanded drug prices need to fall in the US.
The market in the United States has long been known as a gold mine for the pharmaceutical companies as they charge the most in the US.
Trump has railed against the situation in the past.
The Council of States has rejected a popular initiative that would have let foreigners apply for citizenship after just five years, closing the parliamentary door on the biggest attempt in years to loosen one of Europe's strictest naturalisation regimes
The canton of Geneva is set to become the sole owner of the land beneath Stade de Genève, buying out a parcel held by federal railways CFF for CHF 15.84 million
The Swiss National Bank has kept its key interest rate at zero, sticking with a policy that has held since June 2025 even as oil-driven inflation ticks higher